Item 5.07 Submission of Matters to a Vote of Security Holders.

The 2020 annual meeting of stockholders of Enzon Pharmaceuticals, Inc. (the "Company") was held on December 18, 2020. At the 2020 annual meeting of stockholders, the Company's stockholders voted on the following matters as described in the Company's proxy materials: (1) the election of three directors, each for a one-year term expiring at the Company's next annual meeting of stockholders and until such director's successor is elected and qualified, (2) the ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020, and (3) the approval, on an advisory basis, of the compensation of the Company's named executive officers. A total of 58,574,227 shares of common stock were present or represented by proxy at the 2020 annual meeting of stockholders, representing approximately 79% of the total shares of common stock entitled to vote at the 2020 annual meeting of stockholders.





     1.   Election of Directors - The Company's stockholders elected each of the
          following individuals as a director for a one-year term expiring at the
          Company's next annual meeting of stockholders and until such director's
          successor is elected and qualified, as set forth below:




  Nominee             Votes For    Votes Against   Abstentions   Broker Non-Votes
  Jordan Bleznick     39,201,636      637,564        212,600        18,522,427
  Jennifer McNealey   39,335,085      494,126        222,589        18,522,427
  Randolph C. Read    39,208,776      632,093        210,931        18,522,427




     2.   Ratification of the appointment of EisnerAmper LLP as the Company's
          independent registered public accounting firm for the fiscal year ending
          December 31, 2020 - This proposal was approved as set forth below:




  Votes For    Votes Against   Abstentions
  57,634,566      390,379        549,282




     3.   Approval, on an advisory basis, of the compensation of the Company's
          named executive officers - This proposal was approved as set forth
          below:




  Votes For    Votes Against   Abstentions   Broker Non-Votes
  38,925,246      905,239        221,315        18,522,427

© Edgar Online, source Glimpses